Diabetic Nephropathy Flashcards

1
Q

diabetes mellitus - defined

A

*a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both
*the chronic hyperglycemia is associated with long-term damage, dysfunction, and failure of various organs, especially the eyes, KIDNEYS, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

type 1 diabetes mellitus

A

*autoimmune disease characterized by:
-antibody and cell-mediated destruction of pancreatic islet cells, resulting in ABSOLUTE DEFICIENCY OF INSULIN SECRETION & absence of circulating c-peptide
*all patients eventually require insulin treatment
*may occur at any age but commonly in childhood and prior to age 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

type 2 diabetes mellitus

A

*insulin resistance + insulin deficiency
*part of the metabolic syndrome, along with HTN, HLD, obesity
*usually older adults but prevalence increasing in children
*largest and fasting growing group requiring RRT (dialysis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

leading cause of kidney disease & ESRD in the US

A

diabetic nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

diabetic nephropathy - overview

A

*occurs in T1DM, T2DM, and secondary forms of DM (pancreatitis, pancreatectomy)
*glomerulopathy characterized by structural and functional changes:
-structural: thickened GBM, expansion of mesangial matrix, glomerular sclerosis
-functional: persistent albuminuria, worsening HTN, progressive decline in GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

diabetic nephropathy - pathogenesis (overview)

A
  1. hyperglycemia → nonenzymatic glycation of tissue proteins → mesangial expansion → GBM thickening and increased permeability
  2. hyperfiltration (glomerular HTN and increased GFR) → glomerular hypertrophy and glomerular scarring (glomerulosclerosis) → further progression of nephropathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

diabetic nephropathy: glomerular hyperfiltration

A

*commonly seen in early diabetes
*result of afferent arteriolar dilation / efferent vasoconstriction
*mechanism: glucose-dependent effects on arteriole; range of vasoactive mediators

→ increase in glomerular hydrostatic pressure
→ increased protein spilling in filtrate
→ increased inflammation due to tubular loading

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

effect of ACEi or ARB on diabetic nephropathy

A

*ACEi / ARB block Ang II-mediated constriction of the efferent arteriole
*helps to lower glomerular hypertension and hydrostatic pressure
*helps to reduce progression of nephropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

diabetic nephropathy: renal hypertrophy

A

*early hyperfiltration is associated with organomegaly and glomerulomegaly
1. organomegaly: diabetic kidneys are increased in size (by several centimeters)
2. glomerulomegaly: increased number of capillary loops and filtration surface due to hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

diabetic nephropathy: mesangial expansion & nodule formation

A

*hyperglycemia directly promotes mesangial expansion and injury
*high blood sugar → increased intracellular glucose → increased mesangial expansion and increased matrix production
*over time, leads to increased advanced glycation end products (AGEs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

diabetic nephropathy: development of proteinuria

A

*widening of GBM results from:
-accumulation of type IV collagen
-net reduction in negatively charged proteoglycans (loss of charge barrier)
*results in leakage of proteins into the urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

diabetic nephropathy: tubulointerstitial fibrosis

A

*important structural changes that correlate to progression of DN are:
-degree of mesangial expansion
-severity of tubulointerstitial disease
*tubulointerstitial changes start early in process and not only correlate with renal function but also with prognosis

*mechanism: release of factors (esp. TGF-beta) and other cytokines from glomerulus → tubular reabsorption of endocytosed protein → renal ischemia/hypoxia from progressive hyalinosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

natural history of diabetic nephropathy

A
  1. renal hypertrophy & hyperfiltration
    -elevated GFR and urine albumin excretion rate; associated with glomerular and tubular hypertrophy and enlarged kidneys
  2. normoalbuminuria with an elevated GFR (5-10 years)
    -increased mesangial matrix
  3. microalbuminuria (5-15 years)
    -30 to 300 mg albumin/24 hours
    -increase in GBM thickness and mesangial volume
  4. overt proteinuria (10-20 years)
    -300+ mg albumin/g of creatinine
  5. decline in GRF (15-25 years)
    -ESRD (after 5 to 7 years of nephrotic-range proteinuria)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

risk factors for developing diabetic nephropathy

A

*incidence greater in:
-race: African Americans (3-6x), Pima Native Americans
-genetics: those with a diabetic sibling or parent with diabetic nephropathy
-increased duration of diabetes
-males slightly higher
-higher systemic blood pressures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

screening for diabetic nephropathy

A
  1. check urine microalbumin levels (early morning sample, at least 2 occasions)
  2. 24hr collection - gold standard
  3. untimed MICROALBUMIN/CREATININE RATIO

note - persistent microalbuminuria = 30-300 mg/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

factors that can transiently increase urine albumin excretion rate (UAER)

A

*strenuous exercise
*oral protein intake
*UTI
*infection

17
Q

who to screen for diabetic nephropathy?

A

*T1DM for > 5 years: screen annually
*T2DM, from time of dx: screen annually

*individuals with an elevated UAER > 30 mg/day should be screened every 6 months

18
Q

advantage of screening for diabetic nephropathy

A

*MICROALBUMINURIA predicts HIGH renal and cardiovascular risk

19
Q

diabetic nephropathy - clinical features

A

*persistent albuminuria
*worsening hypertension
*progressive decline in GFR
*microvascular and macrovascular complications

20
Q

diabetic nephropathy - diagnosis

A

*based on presence of persistent albuminuria
*biopsy is the DEFINITIVE means of dx
*additional diagnostic support:
-ultrasound demonstrating large kidney size
-presence of diabetic retinopathy
-lack of RBC cast or macroscopic hematuria
-no evidence of other systemic illnesses

21
Q

guidelines for diagnosis of diabetic nephropathy in T1DM pts

A

*microalbuminuria should be attributed to diabetes if:
-diabetic retinopathy is present
AND/OR
-diabetes duration is at least 10 years

22
Q

guidelines for diagnosis of diabetic nephropathy in T2DM pts

A

*microalbuminuria should be attributed to diabetes if:
-diabetic retinopathy is present
OR
-patient progresses to macroalbuminuria

23
Q

when to consider kidney biopsy in diabetic patients

A

*accelerated renal failure (rapid decline in renal function with minimal proteinuria)
*rapidly increasing protein excretion or acute onset nephrotic syndrome
*refractory HTN
*macroscopic hematuria or active urine sediment
*s/s of another systemic disease

24
Q

diabetic nephropathy - pathology

A

*thickening of GBM
*mesangial matrix expansion
*glomerular sclerosis
*arteriolar hyalinosis (both afferent and efferent)
*decreased podocytes
*Kimmelstein-Wilson Nodules

25
Q

diabetic nephropathy - treatments

A

*ACEi/ARB
*SGLT2 inhibitors
*goal: minimize risk factors for progression

26
Q

risk factors for progression of diabetic nephropathy

A

*worsening proteinuria
*poor glycemic control
*hypertension
*genetic predisposition
*male sex
*other: HLD, tobacco use, obesity, low birth weight

27
Q

proteinuria reduction in diabetic nephropathy

A

*ACEi/ARB = first line
*NDP CCBs (verapamil, diltiazem)
*aldosterone antagonists (spironolactone, eplerenone)

*goal = minimize proteinuria

28
Q

glycemic control in diabetic nephropathy

A

*evidence for tight glycemic controlling in type 1 DM
*goal = HbA1C < 7.0

29
Q

hypertension control in diabetic nephropathy

A

*goal < 130/80
*ACEi/ARB and salt restriction

30
Q

hyperlipidemia control in diabetic nephropathy

A

*purpose: microalbuminuria is an INDEPENDENT risk factor for CV disease
*goal: LDL < 100 or < 70 (if other risk factors)
*statins

31
Q

ways to slow progression of diabetic nephropathy - overview

A
  1. minimize proteinuria w/ ACEi or ARB
  2. glucose control
  3. control HTN w/ ACEi or ARB
  4. control HLD (statins)
  5. adjunct therapy
  6. RAAS blockade (ACEi/ARB)
  7. SGLT2 inhibitors